Prudential Financial’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,399
| Closed | -$334K | – | 2421 |
|
|
2025
Q2 | $334K | Buy |
3,399
+601
| +21% | +$56.9K | ﹤0.01% | 2067 |
|
|
2025
Q1 | $259K | Buy |
2,798
+390
| +16% | +$36K | ﹤0.01% | 2009 |
|
|
2024
Q4 | $219K | Sell |
2,408
-125
| -5% | -$11.5K | ﹤0.01% | 2067 |
|
|
2024
Q3 | $244K | Hold |
2,533
| – | – | ﹤0.01% | 2462 |
|
|
2024
Q2 | $233K | Sell |
2,533
-205
| -7% | -$19K | ﹤0.01% | 2440 |
|
|
2024
Q1 | $252K | Sell |
2,738
-80
| -3% | -$7.5K | ﹤0.01% | 2397 |
|
|
2023
Q4 | $268K | Buy |
2,818
+448
| +19% | +$41.8K | ﹤0.01% | 2360 |
|
|
2023
Q3 | $221K | Sell |
2,370
-1,225
| -34% | -$113K | ﹤0.01% | 2364 |
|
|
2023
Q2 | $329K | Sell |
3,595
-173
| -5% | -$14.2K | ﹤0.01% | 2269 |
|
|
2023
Q1 | $418K | Buy |
3,768
+229
| +6% | +$19.8K | ﹤0.01% | 2147 |
|
|
2022
Q4 | $296K | Sell |
3,539
-360
| -9% | -$32.5K | ﹤0.01% | 2263 |
|
|
2022
Q3 | $392K | Buy |
3,899
+8
| +0.2% | +$954 | ﹤0.01% | 2181 |
|
|
2022
Q2 | $428K | Buy |
3,891
+163
| +4% | +$20.8K | ﹤0.01% | 2200 |
|
|
2022
Q1 | $643K | Buy |
3,728
+90
| +2% | +$13.4K | ﹤0.01% | 2084 |
|
|
2021
Q4 | $634K | Sell |
3,638
-113
| -3% | -$18.2K | ﹤0.01% | 2109 |
|
|
2021
Q3 | $642K | Sell |
3,751
-12,758
| -77% | -$2.65M | ﹤0.01% | 2038 |
|
|
2021
Q2 | $4.04M | Sell |
16,509
-7,053
| -30% | -$1.85M | 0.01% | 1115 |
|
|
2021
Q1 | $6.24M | Sell |
23,562
-37,016
| -61% | -$10.4M | 0.01% | 943 |
|
|
2020
Q4 | $17.8M | Buy |
60,578
+48,363
| +396% | +$12.4M | 0.03% | 501 |
|
|
2020
Q3 | $2.89M | Buy |
12,215
+916
| +8% | +$208K | 0.01% | 1151 |
|
|
2020
Q2 | $2.24M | Sell |
11,299
-17,151
| -60% | -$3.2M | ﹤0.01% | 1285 |
|
|
2020
Q1 | $5.22M | Buy |
28,450
+5,555
| +24% | +$988K | 0.01% | 899 |
|
|
2019
Q4 | $3.82M | Buy |
22,895
+1,236
| +6% | +$184K | 0.01% | 1254 |
|
|
2019
Q3 | $2.84M | Buy |
21,659
+88
| +0.4% | +$11.5K | ﹤0.01% | 1392 |
|
|
2019
Q2 | $2.62M | Sell |
21,571
-9,350
| -30% | -$1.11M | ﹤0.01% | 1470 |
|
|
2019
Q1 | $3.81M | Sell |
30,921
-39,533
| -56% | -$4.96M | 0.01% | 1260 |
|
|
2018
Q4 | $8.25M | Buy |
70,454
+10,475
| +17% | +$1.23M | 0.01% | 880 |
|
|
2018
Q3 | $7.5M | Buy |
59,979
+10,118
| +20% | +$1.12M | 0.01% | 1031 |
|
|
2018
Q2 | $4.26M | Buy |
49,861
+30
| +0.1% | +$2.2K | 0.01% | 1291 |
|
|
2018
Q1 | $3.01M | Buy |
49,831
+2,500
| +5% | +$142K | ﹤0.01% | 1393 |
|
|
2017
Q4 | $2.5M | Sell |
47,331
-2,500
| -5% | -$132K | ﹤0.01% | 1493 |
|
|
2017
Q3 | $2.79M | Buy |
49,831
+2,154
| +5% | +$114K | ﹤0.01% | 1412 |
|
|
2017
Q2 | $3M | Sell |
47,677
-505
| -1% | -$29.4K | ﹤0.01% | 1362 |
|
|
2017
Q1 | $2.46M | Sell |
48,182
-1,437
| -3% | -$68.5K | ﹤0.01% | 1472 |
|
|
2016
Q4 | $2.12M | Sell |
49,619
-1,690
| -3% | -$71.9K | ﹤0.01% | 1520 |
|
|
2016
Q3 | $2.43M | Sell |
51,309
-21,970
| -30% | -$1.1M | ﹤0.01% | 1414 |
|
|
2016
Q2 | $3.7M | Sell |
73,279
-2,680
| -4% | -$135K | 0.01% | 1263 |
|
|
2016
Q1 | $3.67M | Buy |
75,959
+2,100
| +3% | +$81K | 0.01% | 1261 |
|
|
2015
Q4 | $2.9M | Buy |
73,859
+3,750
| +5% | +$150K | 0.01% | 1329 |
|
|
2015
Q3 | $2.66M | Sell |
70,109
-5,700
| -8% | -$240K | 0.01% | 1327 |
|
|
2015
Q2 | $3.01M | Buy |
75,809
+1,450
| +2% | +$45.2K | 0.01% | 1362 |
|
|
2015
Q1 | $1.99M | Buy |
74,359
+1,700
| +2% | +$48K | ﹤0.01% | 1593 |
|
|
2014
Q4 | $2.13M | Buy |
72,659
+1,500
| +2% | +$37K | ﹤0.01% | 1440 |
|
|
2014
Q3 | $1.44M | Sell |
71,159
-2,142
| -3% | -$41.3K | ﹤0.01% | 1583 |
|
|
2014
Q2 | $1.23M | Buy |
73,301
+1,342
| +2% | +$19K | ﹤0.01% | 1745 |
|
|
2014
Q1 | $1.07M | Buy |
71,959
+700
| +1% | +$10.8K | ﹤0.01% | 1725 |
|
|
2013
Q4 | $1.04M | Sell |
71,259
-34,900
| -33% | -$562K | ﹤0.01% | 1740 |
|
|
2013
Q3 | $1.83M | Sell |
106,159
-21,416
| -17% | -$318K | ﹤0.01% | 1468 |
|
|
2013
Q2 | $1.48M | Buy |
+127,575
| New | +$1.46M | ﹤0.01% | 1531 |
|
Other funds holding AMED
IA
MCI
HNB
Prudential Financial's AMED Position: Q3 2025 in Review
Prudential Financial sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,399 shares — an estimated $334K sold.
Prudential Financial first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $17.8M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Prudential Financial reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Prudential Financial sold 3,399 Amedisys shares in Q3 2025, an estimated $334K.
- Prudential Financial first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
- Prudential Financial's Amedisys position peaked at $17.8M in Q4 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Prudential Financial's 13F filing for Q3 2025, filed 13 Nov 2025.